Link William J Phd

Director at TARS; Director at RXST; Director at Oyster Point Pharma, Inc., and 3 more

Sold, on record
$38.3M
Dollars the filings state
Form 4 sales
18
Latest Sep 15, 2026
Form 144 notices
0
Proposed sales
Companies
6
Filed as an executive or holder

Companies

Sales by reason

4
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Oyster Point Pharma, Inc.Unusual
    Oct 18 2021

    Sold 550,000 shares at $14.83 ($8.2M)

    Link William J Phd, Director

    Sold 99.1% of holdings ($8.2M position)4,987 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale RXSTUnusual
    Feb 1 +836 days

    Sold 28,250 shares at $49.67 ($1.4M)

    Link William J Phd, Director

    No 10b5-1 planSold 53.8% of holdings ($2.6M position)24,248 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale TARSUnusual
    Aug 12 +193 days

    Sold 35,000 shares at $26.08 ($913k)

    Link William J Phd, Director

    No 10b5-1 planSold 100% of holdings ($913k position)0 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale TARSNo plan
    Sep 8 +392 days

    Sold 27,116 shares at $57.00 ($1.5M)

    Link William J Phd, Director

    No 10b5-1 planSold 15.9% of holdings ($9.7M position)143,332 shares leftFiling

  5. 5 Form 4 sale TARSRoutine
    Dec 15 +98 days

    Sold 22,946 shares at $81.26 ($1.9M)

    Link William J Phd, Director

    10b5-1 planSold 15.1% of holdings ($12.3M position)128,832 shares leftFiling

  6. 6 Form 4 sale TARSRoutine
    Mar 16 +91 days

    Sold 12,500 shares at $68.79 ($860k)

    Link William J Phd, Director

    10b5-1 planSold 9.7% of holdings ($8.9M position)116,332 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale TARSRoutine
    Jun 15 +91 days

    Sold 12,500 shares at $62.12 ($776k)

    Link William J Phd, Director

    10b5-1 planSold 10.5% of holdings ($7.4M position)106,786 shares left0.5x usual sizeFiling

  8. 8 Form 4 sale TARSRoutine
    Sep 15 +92 days

    Sold 12,500 shares at $78.38 ($980k)

    Link William J Phd, Director

    10b5-1 planSold 11.7% of holdings ($8.4M position)94,487 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (18)

Form 144 notices and Form 4 sales by Link William J Phd
Source
Sep 15, 2026TARSDirectorForm 4 sale12,500$980k11.7%RoutineSEC
Jun 15, 2026TARSDirectorForm 4 sale12,500$776k10.5%RoutineSEC
Mar 16, 2026TARSDirectorForm 4 sale12,500$860k9.7%RoutineSEC
Dec 15, 2025TARSDirectorForm 4 sale22,946$1.9M15.1%RoutineSEC
Sep 8, 2025TARSDirectorForm 4 sale27,116$1.5M15.9%No planSEC
Aug 12, 2024TARSDirectorForm 4 sale35,000$913k100.0%UnusualSEC
Feb 1, 2024RXSTDirectorForm 4 sale28,250$1.4M53.8%UnusualSEC
Oct 18, 2021Oyster Point Pharma, Inc.DirectorForm 4 sale550,000$8.2M99.1%UnusualSEC
Dec 1, 2020GKOSDirectorForm 4 sale50,000$3.4M76.4%UnusualSEC
Aug 21, 2019EWDirectorForm 4 sale10,214$2.3M50.8%UnusualSEC
Nov 19, 2018EWDirectorForm 4 sale13,578$2M69.2%UnusualSEC
Nov 15, 2018GKOSDirectorForm 4 sale41,500$2.4M50.6%UnusualSEC
Feb 9, 2018EWDirectorForm 4 sale12,000$1.5M42.9%UnusualSEC
Nov 29, 2016EWDirectorForm 4 sale15,000$1.3M34.9%UnusualSEC
Nov 17, 2016GKOSDirectorForm 4 sale30,000$1M25.5%UnusualSEC
May 31, 2016GKOSDirectorForm 4 sale34,058$817k23.7%Plan not statedSEC
Jan 12, 2007INTRALASE CORPDirectorForm 4 sale250,000$6.1M10.4%Plan not statedSEC
May 9, 2006INTRALASE CORPDirectorForm 4 sale50,000$1M2.0%Plan not statedSEC